Speakers
Johanna Bendell
Head of Oncology
Pfizer
Kate Bingham
Managing Partner
SV Health Investors
Kevin Eggan
Chief Scientific Officer
Biomarin
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
Shaun Grady
Chair, U.K.
AstraZeneca
Stephen Hansen
Director of Biopharma Intelligence
BioCentury Inc.
Susan Hill, Ph.D.
CEO
Mestag Therapeutics
Steve Jackson
Professor of Biology, Cambridge and Group Leader
Cancer Research UK
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
Steve Rees
Senior Vice-President Discovery Sciences
AstraZeneca
James Sabry, M.D., Ph.D.
EVP and CBO
BioMarin Pharmaceutical Inc.
Paul Peter Tak, M.D., Ph.D.
President and CEO
Candel Therapeutics
Sarah Teichmann
Professor and Chair
Cambridge Stem Cell Institute
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
Patrick Vallance, KCB
Minister of State for Science, Research and Innovation
Department for Science, Innovation and Technology
Jérôme Van Biervliet, Ph.D.
Managing Director
VIB
Annelise Vuidepot, PhD
SVP, CTO, Research and UK Site Lead
Immunocore Holdings plc